| Cancer survivorship and care | Lifetime | 41 | US 26 | 99.47 |
| Breast Cancer Treatment Studies | Lifetime | 76 | US 42 | 99.73 |
| Family Support in Illness | Lifetime | 40 | US 29 | 99.23 |
| Childhood Cancer Survivors' Quality of Life | Lifetime | 102 | US 65 | 99.29 |
| Global Cancer Incidence and Screening | Lifetime | 84 | US 47 | 99.31 |
| Medication Adherence and Compliance | Lifetime | 37 | US 30 | 99.01 |
| BRCA gene mutations in cancer | Lifetime | 76 | US 41 | 99.23 |
| Cancer Risks and Factors | Lifetime | 63 | US 31 | 99.45 |
| Cancer-related cognitive impairment studies | Lifetime | 29 | US 24 | 98.69 |
| Reproductive Biology and Fertility | Lifetime | 215 | US 87 | 99.22 |
| Cancer Treatment and Pharmacology | Lifetime | 261 | US 144 | 99.19 |
| HER2/EGFR in Cancer Research | Lifetime | 302 | US 144 | 98.69 |
| Advanced Breast Cancer Therapies | Lifetime | 152 | US 76 | 98.66 |
| Patient-Provider Communication in Healthcare | Lifetime | 362 | US 172 | 96.42 |
| Ovarian function and disorders | Lifetime | 732 | US 273 | 96.99 |
| Male Breast Health Studies | Lifetime | 44 | US 20 | 92.40 |
| Economic and Financial Impacts of Cancer | Lifetime | 504 | US 321 | 95.05 |
| Multiple and Secondary Primary Cancers | Lifetime | 786 | US 341 | 92.91 |
| Ethics in Clinical Research | Lifetime | 772 | US 408 | 90.98 |
| Cancer Risks and Factors | 2021-2025 | 4 | US 2 | 99.65 |
| Cancer survivorship and care | 2021-2025 | 10 | US 5 | 99.40 |
| Childhood Cancer Survivors' Quality of Life | 2021-2025 | 18 | US 11 | 99.25 |
| BRCA gene mutations in cancer | 2021-2025 | 12 | US 8 | 99.10 |
| Breast Cancer Treatment Studies | 2021-2025 | 28 | US 12 | 99.64 |
| Reproductive Biology and Fertility | 2021-2025 | 38 | US 3 | 99.03 |
| Family Support in Illness | 2021-2025 | 41 | US 14 | 96.29 |
| Global Cancer Incidence and Screening | 2021-2025 | 90 | US 36 | 97.68 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 32 | US 16 | 95.67 |
| Cancer-related cognitive impairment studies | 2021-2025 | 32 | US 19 | 95.73 |
| Advanced Breast Cancer Therapies | 2021-2025 | 110 | US 39 | 98.18 |
| Estrogen and related hormone effects | 2021-2025 | 64 | US 29 | 94.64 |
| Cancer Treatment and Pharmacology | 2021-2025 | 191 | US 64 | 96.29 |
| HER2/EGFR in Cancer Research | 2021-2025 | 312 | US 112 | 94.95 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 608 | US 372 | 86.23 |
| Breast Lesions and Carcinomas | 2021-2025 | 526 | US 164 | 81.55 |
| Breast Implant and Reconstruction | 2021-2025 | 637 | US 258 | 80.10 |
| Male Breast Health Studies | 2021-2025 | 51 | US 25 | 69.14 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 757 | US 191 | 61.19 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 989 | US 153 | 56.89 |
